Methotrexate
In brief
- In our pharmacy, you can buy methotrexate without a prescription, with delivery in 9–21 days throughout Australia. Discreet and anonymous packaging.
- Methotrexate is used to treat certain cancers (for example leukaemia and lymphoma), and autoimmune conditions such as rheumatoid arthritis and psoriasis. It is an antimetabolite and folic acid analogue that inhibits dihydrofolate reductase, reducing DNA and RNA synthesis and producing antiproliferative and immunosuppressive effects.
- Usual doses vary by indication: for rheumatoid arthritis and psoriasis a low‑dose weekly regimen of around 7.5–25 mg once weekly is common (often starting 7.5–15 mg weekly); oncology doses are much higher and are calculated by body surface area and specific protocols.
- Forms of administration include oral tablets (2.5–15 mg), oral solution (2–2.5 mg/ml), and parenteral injections (vials, prefilled syringes and autoinjectors) given subcutaneously, intramuscularly or intravenously depending on the regimen.
- Clinical benefit for inflammatory and autoimmune conditions usually begins within 4–8 weeks, though some patients may notice earlier symptom changes.
- Duration of action for low‑dose therapy is typically about one week (hence once‑weekly dosing); intracellular drug metabolites can persist and produce longer cumulative effects.
- Do not drink alcohol or limit intake severely while taking methotrexate because combined use increases the risk of liver toxicity and other adverse effects.
- The most common side effect is nausea (mouth sores/stomatitis, fatigue and elevated liver enzymes are also frequently reported).
- Would you like to try methotrexate without a prescription?
Basic Methotrexate Information
- INN (International Nonproprietary Name): Methotrexate
- Brand Names Available In Australia: not specified
- ATC Code: L01BA01
- Forms & Dosages: Oral tablets 2.5 mg, 5 mg, 7.5 mg, 10 mg, 15 mg; Oral solution 2 mg/ml, 2.5 mg/ml; Injection (vial/ampoule) 10 mg/ml, 25 mg/ml
- Manufacturers In Australia: not specified
- Registration Status In Australia: not specified
- OTC / Rx Classification: not specified
Critical Warnings & Restrictions
High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)
Strong safety banner: Methotrexate is teratogenic, immunosuppressive and can cause life‑threatening bone marrow suppression and hepatotoxicity.
Stop the drug and seek emergency care for severe mouth ulcers, unexplained bruising, high fever, jaundice or shortness of breath.
- High‑risk signs: severe mouth ulcers, persistent high fever, unexplained bleeding or bruising, yellowing of skin/eyes, new or worsening shortness of breath.
- Emergency actions: stop methotrexate, call triple zero (000) for an ambulance if breathing difficulty or collapse, attend nearest emergency department for severe mucosal damage or febrile neutropenia.
- Monitoring checklist: baseline and regular full blood count, liver function tests and renal function prior to and during treatment.
Pregnant people or those planning pregnancy (both male and female partners) must have documented contraception counselling and a negative pregnancy test before starting, in line with specialist guidance.
Breastfeeding, severe renal or hepatic impairment, active infection, elderly with frailty, heavy alcohol use and severe lung disease increase risk of serious adverse effects.
Interaction With Activities (Driving, Workplace Safety Under Australian Law)
Side effects such as dizziness, fatigue or blurred vision can impair driving and the operation of machinery.
If side effects affect alertness do not drive or operate heavy machinery until you are symptom‑free.
Under Australian workplace health and safety law, disclose restrictions if your role is safety‑critical and follow your employer’s policies on medical fitness for duties.
Q&A — “Can I Drive After Taking It In Australia?”
Q: Can I drive after taking methotrexate?
A: Not routinely guaranteed safe.
Driving is allowed unless you experience side effects such as drowsiness, dizziness or visual disturbance.
If affected, do not drive or operate heavy machinery and inform your prescriber and employer if your job is safety‑critical.
Seek pharmacist or doctor advice tailored to your dose and comorbidities.
Usage Basics
INN, Brand Names Available In Australia
The International Nonproprietary Name (INN) is methotrexate.
Global brand names include Rheumatrex, Trexall, Rasuvo, Otrexup, Xatmep, Jylamvo, Maxtrex, Metex and Metoject among others.
Australian availability varies by brand and formulation; check the TGA or local pharmacy stock for current supplies.
Legal Classification (TGA‑Approved, PBS‑Listed)
Methotrexate is classified under ATC code L01BA01 as an antineoplastic and immunomodulating agent.
Many indications attract PBS subsidy subject to PBS criteria and authority scripts.
E‑prescriptions and telehealth prescriptions are accepted and community pharmacies such as Chemist Warehouse, Priceline and TerryWhite Chemmart commonly stock tablets and arrange injectables through suppliers.
- INN
- International Nonproprietary Name: Methotrexate.
- ATC
- L01BA01 — Antimetabolites, folic acid analogues.
- PBS
- Pharmaceutical Benefits Scheme; subsidies depend on indication and authority rules.
- TGA
- Therapeutic Goods Administration; national regulator for medicines.
Dosing Guide
Standard Regimens (PBS Reference Dosing)
Methotrexate dosing depends on indication; low‑dose regimens for inflammatory arthritis and dermatology commonly use once‑weekly oral or subcutaneous dosing.
Oncology regimens use much higher doses, often with leucovorin (folinic acid) rescue.
PBS restrictions help determine which dose and formulation are subsidised for a given indication.
Adjustments For Comorbidities
Reduce dose or avoid methotrexate in significant renal impairment and review with renal function and full blood count monitoring.
Use caution in elderly patients, those with low body weight or liver disease and in heavy alcohol users.
Folic acid supplementation is routinely prescribed to reduce mucosal and hepatic adverse effects.
- Weekly schedule tips: set a fixed weekday, mark a calendar and use phone alarms to avoid daily dosing errors.
- Renal dose adjustment triggers: eGFR decline, rising creatinine or intercurrent dehydration — consult prescriber for dose change.
- Monitoring intervals: baseline FBC, LFTs and renal tests, then regular checks as advised by the specialist (usually every 1–3 months initially).
Q&A — “What If I Miss A Dose?”
Q: What if I miss a dose?
A: Do NOT double up on methotrexate.
Contact your prescriber or pharmacist for specific instructions if a weekly dose is missed.
Do not take an extra dose without professional advice.
Interaction Chart
Food And Drinks (Alcohol, Coffee, Australian Diet Context)
Alcohol increases the risk of hepatotoxicity with methotrexate; advise minimisation or abstinence while on therapy.
Typical coffee intake does not have a critical interaction, but dehydration and binge drinking can worsen renal clearance and risk.
Counsel patients on avoiding binge drinking and watching overall alcohol intake patterns common in Australia.
Common Drug Conflicts
Methotrexate interacts with drugs that increase toxicity or reduce clearance.
High‑risk combinations include trimethoprim, high‑dose NSAIDs, certain antibiotics (some penicillins and sulfonamides) and aminoglycosides.
Proton pump inhibitors have variable effects and warrant caution.
| Drug / Food | Interaction Type | Clinical Recommendation | Evidence Level |
|---|---|---|---|
| Trimethoprim | Increases bone marrow toxicity | Avoid combination or monitor closely | High |
| High‑Dose NSAIDs | Reduce renal clearance, increase toxicity | Avoid or adjust monitoring | Moderate |
| Penicillins / Sulfonamides | Interfere with elimination | Monitor and consider alternatives | Moderate |
| Proton Pump Inhibitors | Variable effect on clearance | Use with caution; review kidney function | Low–Moderate |
| Alcohol | Increases hepatotoxicity | Minimise or abstain | High |
- Top 10 interacting drugs to flag at dispensing include trimethoprim, sulfonamides, high‑dose NSAIDs, aminoglycosides, penicillins, proton pump inhibitors, ciclosporin, tacrolimus, sulfasalazine and leflunomide.
- Pharmacists and prescribers should review all OTC medicines and recent antibiotics before dispensing methotrexate.
User Reports & Trends
Australian patient feedback sources include ProductReview, health forums, Arthritis Australia support groups and pharmacy consultation notes.
Common themes from anonymised reports are nausea, mouth ulcers, hair thinning, fatigue and transient liver function test rises.
Practical issues frequently mentioned are weekly dosing errors and difficulty accessing injectables in some areas.
There is growing patient preference for subcutaneous autoinjectors such as Rasuvo and Otrexup for improved tolerability and bioavailability.
Oral liquid formulations such as Jylamvo and Xatmep help with dose accuracy and paediatric dosing.
| Side Effect | Reported Frequency (Anecdotal) |
|---|---|
| Nausea | Common |
| Mouth Ulcers | Common |
| Fatigue | Common |
| Transient LFT Rise | Occasional |
Use pull quotes from verified reviews and a star‑rating snapshot on the product page to increase trust.
Provide a checklist for patients to record side effects and lab results for their next specialist appointment.
Access & Purchase Options
National Chains (Chemist Warehouse, Priceline, TerryWhite)
Community pharmacies and national chains commonly stock methotrexate tablets and can order injectables through wholesalers.
Confirm PBS item numbers and authority requirements before purchase to ensure subsidy eligibility.
In our online pharmacy, methotrexate is available without a prescription, with discreet delivery to Australia in 9-21 days.
Online Pharmacies And Telehealth E‑Prescriptions
Online Australian pharmacies will supply methotrexate when a valid prescription is presented.
Telehealth e‑prescriptions are accepted by community pharmacies across Australia.
Be cautious of international suppliers due to regulatory and cold‑chain concerns for injectables.
| Source | Form Available | PBS Status | Typical Wait Time |
|---|---|---|---|
| Chemist Warehouse | Tablets; may order injectables | Varies by item | Same day to 3 days |
| Priceline | Tablets; can arrange special order | Varies by item | 1–3 days |
| TerryWhite Chemmart | Tablets; injectables via clinic supply | Varies by item | 1–4 days |
| Online Australian Pharmacy | Tablets, oral solutions | Varies by item | 2–7 days |
- What to bring to pharmacy: valid script, photo ID, medication list and pregnancy test if applicable.
- Rural patients should consider advance scripting, local nurse clinics for injections and telehealth follow‑up to reduce travel.
Mechanism & Pharmacology
Simplified Explanation
Methotrexate is a folic acid analogue that inhibits dihydrofolate reductase and other enzymes in folate metabolism.
That interference reduces DNA and RNA synthesis in rapidly dividing cells and modulates immune activity, which explains use in cancer and autoimmune disease.
Clinical Terms
At low weekly doses methotrexate acts as an anti‑inflammatory immunomodulator.
At high doses used in oncology it is cytotoxic and requires folinic acid (leucovorin) rescue.
- Folate Antagonist
- Blocks folate pathways needed for nucleic acid synthesis.
- Leucovorin Rescue
- Folinic acid used after high‑dose methotrexate to reduce toxicity.
- Subcutaneous Vs Oral Bioavailability
- Injectable forms and autoinjectors can offer improved bioavailability compared with oral tablets at higher doses.
- Renal Clearance
- Methotrexate is primarily renally excreted; impaired renal function increases toxicity risk.
- Cumulative Hepatotoxicity
- Long‑term use requires liver monitoring and alcohol abstinence where possible.
Indications & Off‑Label Uses
Approved Indications By TGA
Methotrexate is used in oncology indications and for immune‑mediated diseases such as rheumatoid arthritis and severe psoriasis.
PBS listing criteria vary by indication and often require specialist initiation and authority.
Off‑Label Uses In Australian Clinical Practice
Specialists sometimes prescribe methotrexate off‑label for other autoimmune dermatological or rheumatological conditions when evidence supports benefit.
Off‑label use should be under specialist supervision with documented informed consent and a monitoring plan.
| Indication | Typical Route | General Dosing Range | PBS Status |
|---|---|---|---|
| Rheumatoid Arthritis | Oral / Subcutaneous | Weekly low dose (varies) | Often PBS‑listed with authority |
| Psoriasis | Oral | Weekly low dose | Varies by severity and criteria |
| Oncology | Intravenous / High dose | High, protocol dependent | PBS for many cancer regimens |
- Documentation needed for off‑label prescribing: informed consent, monitoring plan and specialist letter where relevant.
Key Clinical Findings
Methotrexate is a first‑line conventional disease‑modifying antirheumatic drug for rheumatoid arthritis and reduces disease activity and structural progression when used with monitoring and folate supplementation.
It is effective in psoriasis at appropriate doses and remains a component of many oncology regimens with well‑characterised toxicity profiles.
Recent trends (2022–2026) show increasing evidence that subcutaneous delivery improves tolerability and bioavailability compared with oral tablets.
| Outcome Measure | Use | Monitoring Interval | Key Safety Threshold |
|---|---|---|---|
| DAS28 | Rheumatoid Arthritis Activity | As per rheumatologist | Significant worsening prompts therapy review |
| PASI | Psoriasis Severity | As per dermatologist | Worsening or hepatotoxicity requires reassessment |
| LFTs / FBC | Safety Monitoring | Baseline then regular intervals | Marked elevation or cytopenia — stop and seek review |
Alternatives Matrix
PBS‑Listed Alternatives Comparison Table
| Drug | Mechanism | PBS Availability | Route | Onset | Monitoring Burden | Suitability In Pregnancy |
|---|---|---|---|---|---|---|
| Sulfasalazine | Anti‑inflammatory | PBS listed | Oral | Weeks to months | Moderate | More suitable than methotrexate |
| Hydroxychloroquine | Immunomodulator | PBS listed | Oral | Weeks | Low to moderate | Safer in pregnancy than methotrexate |
| Leflunomide | Pyrimidine synthesis inhibitor | PBS listed | Oral | Weeks | High | Not suitable in pregnancy |
| Biologic Agents (e.g., TNF inhibitors) | Targeted immunomodulation | PBS with authority | Injection/Infusion | Weeks | High | Varies by agent |
Pros And Cons Checklist
- Methotrexate Pros: oral dosing options, established efficacy, lower cost under PBS for many indications.
- Methotrexate Cons: teratogenicity, regular monitoring needed, potential hepatotoxicity and bone marrow suppression.
- Biologics Pros: targeted action, useful when conventional DMARDs fail.
- Biologics Cons: higher cost, infusion logistics and PBS authority requirements.
Common Questions
Can I drink alcohol?
Minimise or avoid alcohol while on methotrexate due to increased hepatotoxicity risk.
How often are blood tests?
Baseline tests then periodic full blood count, liver function and renal function monitoring as advised by the prescriber.
Can I plan pregnancy?
Do not start pregnancy while on methotrexate and seek specialist advice about timing conception; both sexes may need to stop months before attempting pregnancy under specialist guidance.
Are vaccines safe?
Avoid live vaccines while immunosuppressed and ensure routine vaccinations are up to date before starting methotrexate where possible.
- Pharmacy counselling checklist: confirm weekly dosing and route, provide written schedule and dosing card, advise folic acid and alcohol restrictions, review other medicines and vaccination status, and give emergency instructions.
- Top patient questions should have short Q+A cards on the product page with clear “When to call urgent care” tags.
Price & Access Comparison Table
Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required
| Source | Form Available | Typical Private Price Range | PBS Subsidy | Prescription Required |
|---|---|---|---|---|
| Chemist Warehouse | Tablets | $15–$60 (estimate) | Varies by item | Yes |
| Priceline | Tablets | $20–$70 (estimate) | Varies by item | Yes |
| TerryWhite Chemmart | Tablets, injectables via order | $20–$90 (estimate) | Varies by item | Yes |
| Online Australian Pharmacy | Tablets, oral solutions | $18–$80 (estimate) | Varies by item | Yes |
| Hospital Pharmacy | Injectables, oncology formulations | Often bulk dispensed | Usually PBS for in‑patient use | Yes |
Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability
- Ensure you have a valid script and photo ID.
- Check PBS entitlement and item numbers before attending the pharmacy.
- Confirm the pharmacy can supply the chosen formulation and arrange special order early for injectables in rural areas.
Registration & Regulation
TGA Approval
Methotrexate products are registered by the Therapeutic Goods Administration and specific brand approvals vary.
Check the TGA Australian Register of Therapeutic Goods (ARTG) for the exact product and formulation registration.
PBS Subsidy Details
PBS listings and authority requirements differ by indication and product; prescribers must meet PBS eligibility criteria for subsidy.
Pharmacists should verify authority numbers and concession status at dispensing.
- ARTG
- Australian Register of Therapeutic Goods — check product registrations.
- PBS Authority
- Specific codes required for subsidised supply of certain items.
- TGA Adverse Event Reporting
- Report suspected adverse reactions to the TGA’s reporting system.
Pharmacies should document and report adverse events promptly and counsel patients on how to report side effects to the TGA.
Storage & Handling
Household Storage In Australian Climate (Heat/Humidity)
Store tablets and oral solutions below 25°C in their original packaging away from children and pets.
Protect medicines from direct sunlight and humid locations such as bathrooms, and avoid leaving medications in cars in hot weather.
Cold‑Chain Handling For Pharmacies
Some injectable presentations may require refrigeration; check the product label for storage conditions.
Pharmacies must follow cold‑chain protocols for storage and transport and must not dispense items that show evidence of temperature breach or damage.
Disposal of unwanted methotrexate should follow hazardous pharmaceutical waste procedures and not be flushed or thrown in the household bin.
- Patient checklist: store below 25°C, keep in original container, do not use if discoloured or damaged, return unwanted medicines to a pharmacy for safe disposal.
- Pharmacy SOP checklist: verify cold chain logs, inspect packaging before dispensing and document any temperature excursions.
Guidelines For Proper Use
Australian Pharmacist Counselling Style
Confirm the indication and weekly dosing regimen, and verify whether the dose is oral or subcutaneous.
Check contraception status and pregnancy testing where applicable and ensure baseline and ongoing monitoring tests are arranged.
Provide a written dosing card, advise on folic acid supplementation and counsel on signs of infection and when to stop medication.
Patient Advice From PBS And National Health Authorities
Align counselling with PBS criteria, TGA Product Information and specialist society guidance for rheumatology or dermatology.
Encourage shared decision‑making and document informed consent when discussing teratogenic risks and monitoring plans.
- Patient handout should include a weekly calendar, emergency symptoms, storage advice, list of drugs to avoid and contact details for GP and specialist.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 9-14 days |
| Melbourne | Victoria | 9-14 days |
| Brisbane | Queensland | 9-14 days |
| Perth | Western Australia | 9-14 days |
| Adelaide | South Australia | 9-14 days |
| Canberra | Australian Capital Territory | 9-14 days |
| Hobart | Tasmania | 9-14 days |
| Darwin | Northern Territory | 9-14 days |
| Gold Coast | Queensland | 9-14 days |
| Newcastle | New South Wales | 9-14 days |
| Wollongong | New South Wales | 9-14 days |
| Geelong | Victoria | 9-14 days |
| Townsville | Queensland | 14-21 days |
| Cairns | Queensland | 14-21 days |